Over-the-counter use of short-acting beta-2 agonists: a systematic review

BACKGROUND: The widespread use of short-acting beta-2 agonists (SABA) as an as-needed treatment for asthma is well-established. However, excessive use of SABA has been linked to undesirable outcomes such as increased risk of asthma attacks, exacerbations, and even death. The availability of SABA as...

Descripción completa

Detalles Bibliográficos
Autores principales: Loh, Zhe Chi, Hussain, Rabia, Ong, Siew Chin, Saini, Bandana, Muneswarao, Jaya, ur-Rehman, Anees, Babar, Zaheer-Ud-Din
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561505/
https://www.ncbi.nlm.nih.gov/pubmed/37814312
http://dx.doi.org/10.1186/s40545-023-00627-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561505/
https://www.ncbi.nlm.nih.gov/pubmed/37814312
http://dx.doi.org/10.1186/s40545-023-00627-z

Ejemplares similares